Quercus ilex (Holm Oak Acorn)

Quercus ilex (Holm Oak) acorns contain polyphenols including tannins, gallic acid, and flavonoids that drive their biological activity. These compounds exert antioxidant effects by scavenging free radicals and may suppress HPV-driven tumor development through modulation of oxidative stress pathways.

Origin & History

Quercus ilex (Holm Oak) is an evergreen tree native to the Mediterranean region, producing nutrient-dense acorns traditionally harvested as wild food. The acorn extract is typically prepared as an infusion by heating in water at 90°C or using solvents like ethyl lactate:water (50:50 v/v), yielding phenolic-rich preparations containing tannins, flavonoids, and phenolic acids.

Historical & Cultural Context

While specific medicinal uses for Quercus ilex acorns are not documented in available sources, holm oak is a dominant species in Mediterranean agrosilvopastoral systems like the Spanish 'dehesa.' Acorns are noted for unexplored pharmacological properties and potential use as antioxidant animal feed additives.

Health Benefits

• May reduce skin lesions: In transgenic mice, oral administration reduced HPV16-induced squamous cell carcinomas at 0.06-0.09 g/mL doses (preliminary evidence, PMID: 39829663)
• Demonstrates antioxidant activity: Extract shows DPPH, superoxide, and nitric oxide scavenging properties through polyphenolic compounds (in vitro evidence only)
• Exhibits antimicrobial properties: Methanol leaf extracts inhibited 27% of 132 bacterial strains at MIC 125-500 μL/mL (in vitro evidence, PMID: 15103667)
• Supports adaptive stress responses: Increases C-rich metabolites like quinic acid and quercitol in response to biotic challenges (mechanistic studies only)
• May enhance biotic stress resistance: Wound-induced metabolic shifts include elevated glucose, asparagine, and choline (preclinical evidence)

How It Works

Holm oak acorn polyphenols — including hydrolyzable tannins, gallic acid, and quercetin derivatives — donate hydrogen atoms to neutralize DPPH, superoxide, and nitric oxide radicals, reducing oxidative damage at the cellular level. In HPV16 transgenic mouse models, oral administration appeared to downregulate keratinocyte hyperproliferation and squamous cell transformation, possibly by inhibiting NF-κB-mediated inflammatory signaling and reducing reactive oxygen species that drive oncogenic progression. Tannins may also chelate metal ions involved in Fenton-type reactions, further limiting oxidative stress.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Quercus ilex acorn extract. The primary evidence comes from a 2024 mouse study (n=36) showing reduced skin lesions in HPV16-induced carcinomas (PMID: 39829663) and in vitro antimicrobial testing (PMID: 15103667).

Clinical Summary

Current evidence for Quercus ilex acorn extract is limited to preclinical studies with no completed human clinical trials published to date. One study using HPV16 transgenic mice (PMID: 39829663) demonstrated reduced squamous cell carcinoma lesions following oral administration at concentrations of 0.06–0.09 g/mL, representing preliminary but not conclusive evidence. In vitro assays consistently show significant DPPH, superoxide, and nitric oxide scavenging activity from polyphenol-rich extracts, supporting an antioxidant mechanism. Until randomized controlled trials in humans are conducted, all benefit claims remain speculative and should be interpreted with caution.

Nutritional Profile

Holm Oak acorns contain moderate macronutrient content typical of Quercus species: carbohydrates ~50-60% dry weight (primarily starch ~40-50%, with some simple sugars), fats ~5-15% dry weight (oleic acid as dominant fatty acid ~55-65% of lipid fraction, linoleic acid ~15-20%, palmitic acid ~10-15%), and protein ~4-8% dry weight (containing essential amino acids including leucine, valine, and glutamic acid). Crude fiber content ranges ~3-6% dry weight. Key bioactive compounds include hydrolyzable tannins (gallotannins and ellagitannins, particularly vescalagin and castalagin) at ~2-10% dry weight depending on maturity, condensed tannins (proanthocyanidins), phenolic acids (gallic acid, ellagic acid, valoneic acid dilactone), and flavonoids (quercetin, kaempferol glycosides). Total polyphenol content reported at ~15-80 mg GAE/g dry extract depending on extraction method. Mineral content includes potassium (~300-500 mg/100g), calcium (~30-60 mg/100g), magnesium (~50-80 mg/100g), phosphorus (~100-150 mg/100g), and iron (~2-4 mg/100g). Vitamin E (tocopherols) present at low levels (~1-3 mg/100g). Bioavailability note: High tannin content significantly reduces protein digestibility and mineral absorption (particularly iron and zinc) through chelation; traditional processing (leaching, roasting) reduces tannins by 60-80% and improves nutritional bioavailability. Polyphenol bioavailability is moderate, with ellagitannins converted to urolithins by gut microbiota.

Preparation & Dosage

No clinically studied human dosages exist. Preclinical mouse studies used acorn infusion extract at 0.03-0.09 g/mL in drinking water (approximately 0.6-1.8 g/kg/day), with efficacy observed at 0.06-0.09 g/mL over 28 days. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Green Tea Extract, Vitamin C, Resveratrol, Grape Seed Extract

Safety & Interactions

No formal human safety trials have been published for Quercus ilex acorn extract, making a comprehensive adverse effect profile impossible to establish at this time. High tannin content, common in oak-derived products, may cause gastrointestinal irritation, constipation, or reduced absorption of dietary iron and certain medications such as tetracyclines and iron supplements if taken concurrently. Due to the absence of reproductive safety data, use during pregnancy or breastfeeding is not recommended. Individuals on anticoagulants or hepatotoxic medications should consult a healthcare provider, as high-dose tannin exposure has been associated with liver stress in animal models.